Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin

Intern Med. 2019 May 1;58(9):1329-1333. doi: 10.2169/internalmedicine.1446-18. Epub 2019 Jan 10.

Abstract

A 76-year-old Japanese woman with recurrent hepatocellular carcinoma presented with acute exacerbation of idiopathic interstitial pneumonia (AE-IIP) after transcatheter arterial therapy using miriplatin. She had a history of preexisting IIP five years before presenting at our hospital. On day 4 after transcatheter arterial therapy, she complained of shortness of breath. Subsequently, she developed acute respiratory failure on day 11 after transcatheter arterial therapy. Chest computed tomography revealed extensive ground-glass opacity and traction bronchiectasis in bilateral lung fields; subsequently, she was diagnosed with AE-IIP triggered by transcatheter arterial therapy using miriplatin. Despite systemic administration of high-dose corticosteroid and cyclophosphamide, she died of respiratory failure on day 36.

Keywords: acute exacerbation; idiopathic interstitial pneumonia; miriplatin; transcatheter arterial therapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Hepatocellular / drug therapy*
  • Catheterization, Peripheral
  • Cyclophosphamide / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Idiopathic Interstitial Pneumonias / chemically induced*
  • Infusions, Intra-Arterial
  • Liver Neoplasms / drug therapy*
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects*
  • Respiratory Insufficiency / chemically induced
  • Respiratory Insufficiency / pathology
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • miriplatin
  • Cyclophosphamide